Skip to main content
OpenTrials

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

13 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Recruiting

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

NCT07222800

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +13 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Ironwood Cancer & Research Centers Gilbert, Arizona, United States
  • Ironwood Cancer & Research Centers Glendale, Arizona, United States
  • Ironwood Cancer & Research Centers Goodyear, Arizona, United States
View all 285 locations
View Trial Details
Recruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177

NCT04949282

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +19 more
Locations
  • Hospital Clínico Universitario de Santiago Santiago de Compostela, A Coruña, Spain
  • Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain
  • Hospital Unviersitari Son Espases Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
View all 20 locations
View Trial Details
Completed

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

NCT06048146

Conditions
Cancer of Rectum and Anus, Colorectal Neoplasms, Digestive System Diseases, +16 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing, Beijing Municipality, China
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Usefulness of GI-GENIUS in FIT-based Colorectal Cancer Screening Program.

NCT04673136

Conditions
Adenoma Colon, Colonic Diseases, Colonic Polyp, +18 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital Clinic Barcelona Barcelona, Spain
  • Complexo Hospitalario de Ourense Ourense, Spain
  • Hospital Universitario Central de Asturias Oviedo, Spain
View Trial Details

Related conditions